O
HUM icon

OrbiMed’s Humana HUM Stock Holding History

OrbiMed’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,000
Closed -$11.2M – 134
2023
Q2 		$11.2M Buy
+25,000
New +$12.6M 0.2% 84
2017
Q1 		– Sell
-100,000
Closed -$20.4M – 139
2016
Q4 		$20.4M Buy
+100,000
New +$19.1M 0.26% 69

Other funds holding HUM

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OrbiMed's HUM Position: Q2 2026 in Review

OrbiMed opened a new position in Humana (HUM) in Q2 2026: 164,100 shares worth $65.2M. The stake represents 1.21% of the portfolio and ranks #25 among its holdings. This is a return to the name: OrbiMed previously reported a position in HUM as recently as Q4 2023.

OrbiMed first reported a position in HUM in Q1 2016 and has held it in 29 quarters since. The position peaked at $185M in Q2 2017. 926 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • OrbiMed held 164,100 shares of Humana worth $65.2M as of Q2 2026.
  • Humana was a new OrbiMed position in Q2 2026.
  • Humana made up 1.21% of OrbiMed's portfolio in Q2 2026, its #25 holding.
  • OrbiMed first reported a position in Humana in Q1 2016 and has held it in 29 quarters since.
  • OrbiMed's Humana position peaked at $185M in Q2 2017.
  • 926 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.